Patricia Doolin
Family · Columbia, KYNPI 1427549559
Payments from drug & device makers
Across 154 payments — averaging $16.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$471
- AbbVie$407
- Alkermes, Inc.$365
- AstraZeneca$226
- Vanda Pharmaceuticals Inc.$182
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$135
- plus $692 from 17 others
What the payments were for
- Food & beverage$2,478100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $471 |
| AbbVie | 32 | $407 |
| Alkermes, Inc. | 26 | $365 |
| AstraZeneca | 10 | $226 |
| Vanda Pharmaceuticals Inc. | 15 | $182 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $135 |
| Pfizer | 5 | $103 |
| Amgen | 5 | $94 |
| Lilly USA, LLC | 6 | $93 |
| GSK | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 5 | $52 |
| Boehringer Ingelheim | 3 | $50 |
| Novo Nordisk | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $27 |
| Merck | 2 | $27 |
| Averitas Pharma Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $19 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$115
How this compares
$2,478 in reported general payments places this provider in the 80th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 155 | $166,191 |
| FarxigaDapagliflozin Propanediol | 152 | $134,274 |
| OzempicSemaglutide | 79 | $87,170 |
| JardianceEmpagliflozin | 67 | $51,002 |
| EliquisApixaban | 60 | $46,705 |
| TrulicityDulaglutide | 33 | $31,699 |
| LinzessLinaclotide | 48 | $25,746 |
| RexultiBrexpiprazole | 12 | $24,719 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $21,889 |
| VraylarCariprazine Hcl | 11 | $21,037 |
| XareltoRivaroxaban | 24 | $15,277 |
| JanuviaSitagliptin Phosphate | 22 | $14,778 |
| MyrbetriqMirabegron | 26 | $14,363 |
| DapagliflozinDapagliflozin Propanediol | 28 | $13,212 |
| Nurtec OdtRimegepant Sulfate | 12 | $13,152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $93 | $197,889188 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $226 | $156,163181 claims |
| Novo NordiskOzempic | $50 | $87,17079 claims |
| PfizerEliquis, Nurtec Odt | $103 | $59,85772 claims |
| Boehringer IngelheimJardiance | $50 | $51,00267 claims |
| AbbVieLinzess, Vraylar | $407 | $46,78259 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $27 | $24,71912 claims |
| MerckJanuvia | $27 | $14,77822 claims |
| Astellas Pharma US IncMyrbetriq | $15 | $14,36326 claims |
| GSKTrelegy Ellipta | $67 | $12,78316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,374 family providers in Kentucky.
Other family in Columbia
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.